What one share of Ac Immune Sa holds
AC Immune is a leading, clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. Our highly differentiated approach aims to overcome the fundamental challenge in this therapeutic area – the high number of co-pathologies driving disease development and progression and the urgent need for more tailored therapeutic regimens.
Ac Immune Sa’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.04 |
|---|---|
| Profit | −$0.84 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.84 |
| Cash and investments | $0.33 |
| Book value | $0.56 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $0.88 | $0.46 | $0.01 | $0.99 | — | $1.63 |
| 2016 | $0.47 | −$0.14 | $0.02 | −$0.13 | — | $2.80 |
| 2017 | $0.36 | −$0.47 | $0.03 | −$0.43 | — | $2.09 |
| 2018 | $0.11 | −$0.84 | $0.03 | −$0.76 | — | $2.67 |
| 2019 | $1.56 | $0.64 | $0.03 | $0.75 | — | $3.92 |
| 2020 | $0.23 | −$0.92 | $0.03 | −$0.91 | — | $3.39 |
| 2021 | $0.00 | −$1.07 | $0.04 | −$1.00 | — | $3.04 |
| 2022 | $0.05 | −$0.89 | $0.02 | −$0.94 | — | $2.19 |
| 2023 | $0.19 | −$0.71 | $0.01 | −$0.80 | — | $1.93 |
| 2024 | $0.31 | −$0.58 | $0.01 | $0.74 | — | $1.23 |
| 2025 | $0.04 | −$0.84 | $0.01 | −$0.84 | — | $0.56 |
Common questions about Ac Immune Sa
How much does one share of Ac Immune Sa earn?
Over its latest fiscal year, Ac Immune Sa lost $0.84 for each share on $0.04 of sales.
Does Ac Immune Sa pay a dividend?
Ac Immune Sa didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Ac Immune Sa’s book value per share?
Ac Immune Sa’s book value is $0.56 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Ac Immune Sa have?
Each share of Ac Immune Sa has $0.33 of cash and investments, as of December 31, 2025.
What is Ac Immune Sa’s free cash flow per share?
−$0.84 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Ac Immune Sa bought back shares?
Ac Immune Sa’s share count rose about 119% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.